Purchase Order 75F40123P00257

The Food and Drug Administration issued a purchase order to Stemcell Technologies Inc., a total small business set-aside, for $24,664 in semi-solid culture media with an award date of August 15, 2023 and ultimate completion date of August 14, 2024. Performance is located in Silver Spring, Maryland. The order procures specialized biological research materials and cell culture media supporting federal health agency research operations. Stemcell Technologies Inc. is a foreign-owned subsidiary of...

This $112,095.00 firm fixed-price purchase order contract was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Stemcell Technologies Inc., a foreign-owned for-profit organization, to provide a STEMvision Instrument. The STEMvision Instrument is a computer-operated bench-top instrument that images and quantifies hematopoietic colonies in colony forming unit (CFU) assays of human bone marrow, peripheral blood, and cord blood. This instrument will...

This is a firm fixed-price purchase order contract awarded by the Office of the Chief Operating Officer, a civilian agency, to Stemcell Technologies Inc., a for-profit Canadian biotechnology company. The contract, valued at $14,677.50, is for the provision of maintenance services for Stemcell Technologies' proprietary research tools and supplies. Stemcell Technologies Inc. is the prime contractor and there is no indication of any major subcontractors. The contract is not set aside for small...

The National Institute on Aging awarded a purchase order to Stemcell Technologies Inc. on July 26, 2017 for $14,749.28, with an ultimate completion date of September 20, 2017. The procurement used no set-aside category and carried firm fixed price terms. Place of performance is Baltimore, Maryland. The order procures specialized biological research materials and instruments from Stemcell Technologies' commercial product line, which includes cell isolation kits, automated cell separators, and...

<p>The NIH Clinical Center awarded a purchase order to Stemcell Technologies Inc. on March 17, 2016, with a ceiling value of $35,087.50 for professional services, with ultimate completion on March 16, 2017. Work is performed in Bethesda, Maryland. The purchase order is priced on a firm fixed-price basis with no set-aside designation. The specific scope of professional services is not detailed in the source.</p>

<p>The NIH Clinical Center awarded a purchase order to Stemcell Technologies Inc. on June 6, 2019, with a ceiling value of $13,577.40 and an ultimate completion date of July 12, 2019. The order is firm fixed price with no set-aside designation. Place of performance is Afghanistan. The source does not disclose the specific goods or services procured under this order.</p>

The National Institute on Drug Abuse awarded a purchase order to Stemcell Technologies Inc. for $162,655.20 on August 5, 2024, for maintenance and repair services for RoboSep-S automated immunomagnetic cell separation equipment. The order carries no set-aside designation. Work is performed at Kent, Washington. The purchase order covers preventive maintenance, software upgrades, and on-site support for government-owned equipment through August 4, 2029. The originating pre-solicitation notice...

<p>The National Institute on Aging issued a purchase order to Stemcell Technologies Inc. on September 7, 2017, for $14,773.50, with final delivery due October 7, 2017. Work is performed in Baltimore, Maryland. The order procures biological research materials and cell culture supplies from Stemcell Technologies' commercial product portfolio, including cell isolation kits, automated cell separation instruments, and related consumables supporting federal health research operations.</p>

<p>The NIH Clinical Center awarded a purchase order to Stemcell Technologies Inc. valued at $28,950.76 on March 25, 2020, for advanced biological research products and laboratory supplies. Work is performed in Bethesda, Maryland. The order carried firm fixed-price pricing with an ultimate completion date of April 30, 2020. No set-aside was used.</p>

<p>The National Institute on Aging awarded a purchase order to Stemcell Technologies Inc. for $6,626.25 on November 27, 2017, with completion targeted for November 28, 2018. Performance takes place in Baltimore, Maryland. The order procures specialized biological research materials or cell culture products from Stemcell Technologies' commercial product portfolio, supplied on a firm fixed-price basis under full-and-open competition.</p>